Kozak & Associates’s Viatris VTRS Stock Holding History
Bought
Maintained
Sold
Other funds holding VTRS
DSA
RCMNY
Kozak & Associates's VTRS Position: Q2 2026 in Review
Kozak & Associates held its Viatris (VTRS) position steady in Q2 2026 at 35 shares worth $572. The position accounts for ﹤0.01% of the portfolio, ranked #399.
Kozak & Associates first reported a position in VTRS in Q3 2021 and has held it in 12 quarters since. The position peaked at $1K in Q4 2022. 1,022 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.
- Kozak & Associates held 35 shares of Viatris worth $572 as of Q2 2026.
- Kozak & Associates left its Viatris share count unchanged in Q2 2026.
- Viatris made up ﹤0.01% of Kozak & Associates's portfolio in Q2 2026, its #399 holding.
- Kozak & Associates first reported a position in Viatris in Q3 2021 and has held it in 12 quarters since.
- Kozak & Associates's Viatris position peaked at $1K in Q4 2022.
- 1,022 funds tracked by Wall St. Rank held Viatris as of Q2 2026.
Based on Kozak & Associates's 13F filing for Q2 2026, filed 2 Jul 2026.